The Brain Cancer Centre

What The Brain Cancer Centre does

The Brain Cancer Centre is a non-profit translational research organization founded in 2021 and headquartered in Parkville, Melbourne, Australia. It is operated by the Walter and Eliza Hall Institute of Medical Research (WEHI) and was established by Carrie's Beanies 4 Brain Cancer to coordinate brain-cancer research, clinical trials, and patient outcomes across Australia. The Centre serves brain-cancer patients, clinicians, and researchers by acting as a coordinating hub for a network of 17 institutional partnerships nationwide, with a stated $30 million commitment to research and clinical-trial activity since inception.

Its core research platforms and programs include BrainPOP — a personalized oncology platform launched in April 2024 that performs genomic and molecular profiling to match brain-cancer patients to targeted therapies; BRAIINSTORM — a drug-discovery and immunotherapy program funded in part by a 2025 ACRF grant; a CAR T cell immunotherapy research line backed by $2.6M of MRFF funding in 2024; the BBB (blood-brain barrier) Program; and an Organoid Precision Medicine program. Outputs have been validated through publication in Nature Medicine in 2025. The Centre operates with approximately six direct employees but coordinates the work of more than 100 researchers across its partner network.

Its funding model is philanthropic and grant-based, with no commercial revenue. Capital is drawn from the Victorian Government (notably a $16M 2025 commitment for BrainPOP), the Medical Research Future Fund, the Australian Cancer Research Foundation, Carrie's Beanies 4 Brain Cancer, and other donors. Leadership comprises CEO Sam McGuane and Co-Heads of Research Strategy Professor Misty Jenkins AO and Dr. Jim Whittle.

Name

The Brain Cancer Centre

Legal name

The Brain Cancer Centre

Website

https://thebraincancercentre.org.au

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

The Brain Cancer Centre is a non-profit translational research organization founded in 2021 in Melbourne, Australia, operated by WEHI. It coordinates 100+ researchers across 17 Australian institutional partnerships to fund brain-cancer clinical trials, drug discovery, and personalized oncology programs such as BrainPOP.

Ownership category

akta.pro rank

Product category

Medical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro industry

PRIMARYHLAKAFAH

Neuro-Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAIAL

Neuro-oncology

Healthcare & Life Sciences/Specialist Medical Practice/Neurology

SECONDARYBPAGACAA

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)

Business & Public Services/Nonprofit, NGO & Social Services/Health & Medical Nonprofits

SECONDARYHLAFAMAL

Clinical Research & Trial Central Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAAACAF

Oncology Gene Therapies (incl. oncolytic vectors & gene-modified approaches)

Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)

SECONDARYHLACAOAL

Decentralized/Hybrid Trial Enablement (DCT) Platforms

Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

• Brain cancer research
• Clinical trial programs
• Immunotherapy development
• Precision medicine oncology
• Translational medical research

Headquarters

HQ city

Parkville, Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Research Grants and Philanthropic Funding: The Brain Cancer Centre operates as a not-for-profit research organisation funded through a combination of grants, philanthropic donations, and government support. Major funding includes ACRF grants, Victorian Government investment, and donations from supporters such as Carrie's Beanies 4 Brain Cancer, Lauries Love, and individual donors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

The Brain Cancer Centre is a not-for-profit medical research organisation that conducts collaborative brain cancer research, develops novel therapies including CAR T cell immunotherapy, organoid-based precision medicine, liquid biopsy diagnostics, and nanobody-based blood-brain barrier drug delivery, and operates clinical trial platforms such as the world-first BrainPOP perioperative trial platform. It coordinates more than 100 researchers across 17 partner hospitals, medical research institutes and universities in Australia, funded by philanthropic donations, government grants, and charity partners.

Product overview

The Brain Cancer Centre is a research organization, not a traditional product company. It operates as a collaborative research hub bringing together medical researchers from hospitals, medical research institutes, and universities across Australia. Its portfolio consists of clinical trial platforms (BrainPOP), research programs (Immunotherapy, Blood-Brain Barrier Program, BRAIN Registry, BRAIN Program), community programs (Consumer Program), and awareness initiatives (The Public Diagnosis). The BRAIINSTORM Program represents its newest AI-powered drug discovery initiative. The Brain Cancer Research Laboratory serves as the central research division, while organoid-informed precision medicine provides patient-specific treatment discovery capabilities. All programs are designed to accelerate the development of new treatments and clinical trials for brain cancer patients.

Differentiator

Problem solved

Functional benefit

Products and services

• BrainPOP (Brain Perioperative Platform) Clinical Trial Program A pioneering perioperative clinical trial platform for brain cancer that enables doctors to precisely see the effect of new drug therapies on a patient's brain cancer by collecting tumour samples before and after treatment, allowing researchers to directly study how drugs work inside the brain. Developed for adult and paediatric brain cancer patients across partner hospitals.
• BRAIINSTORM Program A landmark national research initiative that creates an end-to-end pipeline from AI-powered drug discovery and cutting-edge laboratory models to a dedicated clean room where personalised cell therapies will enable affordable and timely delivery of novel treatments to Australian brain cancer patients, with a focus on high-grade gliomas.
• BRAIN Registry A research data program that captures comprehensive longitudinal data from brain cancer patients from diagnosis throughout their treatment journey, documenting how patients are treated and the impact of current treatments to inform research and care improvements.
• BRAIN Program A research project that gathers and connects information from doctors, researchers and patients to improve understanding and treatment of brain cancer by linking data from patients, hospitals, labs and government sources.
• Blood-Brain Barrier (BBB) Program A collaborative multidisciplinary research program developing innovative strategies — including nanobody-based delivery targeting the transferrin-1 receptor — to allow anti-cancer drugs to effectively penetrate the blood-brain barrier and reach brain tumours.
• Immunotherapy Program Research program developing novel immunotherapy approaches including EphA3-targeted CAR T cell therapy to treat high-grade gliomas in adults and children, with preclinical results showing 100% cure rate in mouse models for high-grade glioma.
• Organoid-Informed Precision Medicine for Glioblastoma A research program that uses 3D organoid replicas of patient tumours (tumour avatars) to test and discover new therapies, accelerate identification of targeted drugs and drug combinations, and improve personalised treatment for brain cancer patients, particularly those with glioblastoma.
• Brain Cancer Research Laboratory A multidisciplinary research laboratory co-led by cancer biology, neuro-oncology and computational sciences experts that uses cutting-edge spatial and single-cell technologies to decode tumour complexity and uncover mechanisms of treatment resistance.
• Consumer Program A community engagement program that invites patients, carers and family members across Australia to join and help ensure research focuses on what truly matters to patients and carers, with full training and support provided to non-specialist participants.

Quantifiable outcome

• World-first clinical trial platform - Brain POP enabling doctors to precisely see drug effects on brain cancer for the first time
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

18 partnerships are on record, tiered core, major and supporting.

• WEHI (Walter and Eliza Hall Institute of Medical Research)coreStrategic or Co-development PartnerWEHI is the primary institutional partner hosting The Brain Cancer Centre. The organisation is managed by WEHI which handles donations and powers the centre's operations. Multiple researchers hold dual appointments at WEHI including Professor Misty Jenkins, Dr Jim Whittle, and others leading key research programs.
• Peter MacCallum Cancer CentrecoreStrategic or Co-development PartnerKey research partner contributing researchers including Dr Jim Whittle (Laboratory Head), Professor Mark Rosenthal (Medical Oncologist), Professor Ben Hogan (Associate Director of Laboratory Research), and Professor Jayesh Desai. Home to the Parkville Cancer Clinical Trials Unit.
• The Royal Melbourne HospitalcoreStrategic or Co-development PartnerClinical partner for BrainPOP trial. Home to Professor Kate Drummond AM (Director of Neurosurgery), contributing surgical expertise and leading CNS Tumours research at VCCC Parkville Precinct.
• The Florey Institute of Neuroscience and Mental HealthmajorStrategic or Co-development PartnerContributing neuroscience expertise through Professor Lucy Palmer's Neural Network Laboratory studying neuron-glioma synapse, and Professor Guillaume Lessene's New Medicines research.
• Monash University / Monash Institute of Pharmaceutical SciencesmajorStrategic or Co-development PartnerPartner in Blood-Brain Barrier Program with Professor Joseph Nicolazzo leading BBB research, and collaborative PhD programs including nanobody delivery research with WEHI.
• The Mark Hughes Foundation Centre for Brain Cancer ResearchmajorStrategic or Co-development PartnerResearch collaborator in the national brain cancer research network, contributing to collaborative research programs.
• Menzies Institute for Medical ResearchmajorStrategic or Co-development PartnerContributing genetic and epigenetic research with Dr Owen Marshall's work on brain development and disease, and Professor Jo Dickinson's Cancer Genetics team.
• Murdoch Children's Research InstitutemajorStrategic or Co-development PartnerPartner in BrainPOP clinical trial program, contributing paediatric expertise to the multidisciplinary Melbourne Biomedical Precinct collaboration.
• The Royal Children's Hospital MelbournemajorStrategic or Co-development PartnerPartner in BrainPOP clinical trial program and paediatric brain cancer research, contributing clinical expertise.
• The Kids Research Institute AustraliamajorStrategic or Co-development PartnerHome to Professor Nick Gottardo and Associate Professor Raelene Endersby's Brain Tumour Research Program focusing on paediatric brain tumours, including medulloblastoma and DIPG research.
• University of Queensland / Frazer InstitutemajorStrategic or Co-development PartnerHome to Professor Brandon Wainwright's Children's Brain Cancer Centre and Professor Di Yu's immunotherapy research. Collaborating on engineering immune recognition of paediatric brain tumours.
• University of MelbournemajorStrategic or Co-development PartnerMultiple researchers hold appointments at University of Melbourne. Partner in BrainPOP trial and neuroscience of brain cancer research.
• University of AdelaidemajorStrategic or Co-development PartnerContributing to paediatric neuro-oncology research through Professor Jordan Hansford at SAHMRI.
• VCCC AlliancemajorStrategic or Co-development PartnerVictorian Comprehensive Cancer Centre Alliance contributing to the VCCC Parkville Precinct and coordinating comprehensive cancer care and research.
• Royal Hobart HospitalsupportingStrategic or Co-development PartnerPartner contributing Professor Rosemary Harrup (Director of Cancer and Blood Services) and genetic research in Tasmania.
• WA Kids Cancer Centre (Telethon Kids)supportingStrategic or Co-development PartnerPartner in Western Australian brain cancer research network.
• Cooperative Trials Group for Neuro-Oncology (COGNO)supportingStrategic or Co-development PartnerNational clinical trials group contributing to brain cancer research coordination.
• ANZCHOG (Australian and New Zealand Children's Haematology and Oncology Group)supportingStrategic or Co-development PartnerPaediatric oncology group with Professor Nick Gottardo as Deputy Chair and CNS Tumours Subgroup Chair, leading COG's upfront clinical trial for WNT-driven medulloblastoma.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• National Brain Tumor Society: US nonprofit funding brain tumor research, advocacy, and patient support; comparable mission, scale, and reliance on philanthropic and federal funding for brain cancer research programs.
• Mark Hughes Foundation Centre for Brain Cancer Research: Australian brain cancer research centre at University of Newcastle; an actual collaborative partner of The Brain Cancer Centre and a directly comparable nonprofit-funded research hub focused on brain cancer.
• Cure Brain Cancer Foundation: Australian nonprofit dedicated to brain cancer research funding and advocacy; overlapping donor base, government relationships, and research funding mandate, making it the closest direct peer in mission and geography.
• Pediatric Brain Tumor Foundation: US nonprofit funding paediatric brain tumour research and family support; directly comparable given The Brain Cancer Centre's significant paediatric research focus (DIPG, medulloblastoma, AT/RT) via partners like MCRI and Kids Research Institute Australia.
• Brain Tumour Research: UK charity dedicated to funding brain tumour research and establishing a network of research Centres of Excellence; directly comparable model of focused, disease-specific research fundraising and partnership building.
• Musella Foundation for Brain Tumor Research: US nonprofit funding brain tumor research and maintaining a clinical trials database; comparable nonprofit research funder and information hub in the brain cancer space.
• The Brain Tumour Charity: UK-based charity funding brain tumour research, support, and awareness; structurally and operationally similar to The Brain Cancer Centre as a non-profit brain-cancer research funder and convener.
• Accelerate Brain Cancer Cure: US nonprofit focused on accelerating brain cancer cures through venture-philanthropy and translational research funding; comparable mission of bridging research to clinical impact in brain cancer.

Broad incumbents

• WEHI (Walter and Eliza Hall Institute of Medical Research): Parent institution and operational backbone of The Brain Cancer Centre; a much larger, broader biomedical research institute whose portfolio extends well beyond brain cancer but which hosts and supports the Brain Cancer Centre's operations.
• QIMR Berghofer Medical Research Institute: Large Australian medical research institute with active brain cancer and oncology programs; comparable broad biomedical research footprint but significantly larger scale than The Brain Cancer Centre's focused brain cancer mission.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BrainCancerCtr
• Facebookfacebook.com/BrainCancerCentre
• LinkedInlinkedin.com/company/brain-cancer-centre
• Instagraminstagram.com/braincancercentre

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Brain Cancer Centre